Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 85 (1) , 53-57
- https://doi.org/10.1016/s0002-9149(99)00606-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- FluvastatinDrugs, 1999
- Long-Term Efficacy and Safety of Fenofibrate and a Statin in the Treatment of Combined HyperlipidemiaThe American Journal of Cardiology, 1998
- New lipid lowering drugs and new effects of old drugsCurrent Opinion in Lipidology, 1997
- Safety and Efficacy of Long-Term Statin-Fibrate Combinations in Patients With Refractory Familial Combined HyperlipidemiaThe American Journal of Cardiology, 1997
- Statins: within-group comparisons, statin escape and combination therapyCurrent Opinion in Lipidology, 1996
- High-dose fluvastatin and bezafibratecombination treatment for heterozygous familial hypercholesterolemiaThe American Journal of Cardiology, 1995
- Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.Heart, 1995
- The role of HMG-CoA reductase inhibitors in the treatment of hyperlipidemia: a review of fluvastatinCurrent Therapeutic Research, 1995
- Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: Comparative analysis with a fluvastatin-cholestyramine combinationThe American Journal of Medicine, 1994
- Comparative evaluation of fibric acid derivatives and HMG-CoA reductase inhibitorsAtherosclerosis, 1992